Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.

Antiviral research - 1 Mar 2015

Laganas Valerie A, Dunn Ewan F, McLaughlin Robert E, Tiong-Yip Choi Lai, Yuzhakov Olga, Isabella Vincent M, Hill Pamela, Yu Qin

Abstract excerpt

Respiratory Syncytial Virus (RSV) is a major cause of lower respiratory tract infections with no effective treatment available. Finding novel inhibitors of RSV is an important first step towards developing an efficacious RSV therapy. Here we report the characterization of three novel classes of RSV replication inhibitors identified through a high throughput RSV replicon screen of ∼1million compounds in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzothiazoles
Share to High-Throughput Screening Assays

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Indoles

Share to Oxadiazoles

Share to Replicon

Share to Respiratory Syncytial Virus, Human

Share to RNA-Dependent RNA Polymerase

Share to Thymine

Source

Identifiers

PMID: 25542974
DOI: 10.1016/j.antiviral.2014.12.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of novel respiratory syncytial virus inhibitors identified by high throughput screen.PMID 25542974Read ↗

Structure-guided design of small-molecule therapeutics against RSV diseaseSemantic proximity Read ↗

Characterization of a Respiratory Syncytial Virus L Protein InhibitorSemantic proximity Read ↗

Drug candidates and model systems in respiratory syncytial virus antiviral drug discovery.Semantic proximity Read ↗

Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitorSemantic proximity Read ↗

EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate modelSemantic proximity Read ↗

Discovery of a Novel Respiratory Syncytial Virus Replication InhibitorSemantic proximity Read ↗

Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA PolymeraseSemantic proximity Read ↗

High-throughput screening of active compounds against human respiratory syncytial virusSemantic proximity Read ↗

Mechanism of Action for Respiratory Syncytial Virus Inhibitor RSV604Semantic proximity Read ↗

Orally active fusion inhibitor of respiratory syncytial virus.Semantic proximity Read ↗

Insights into the Currently Available Drugs and Investigational Compounds Against RSV with a Focus on Their Drug-Resistance ProfilesSemantic proximity Read ↗

Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.